Atlas Trials

Efficacy of Sirolimus-Based, Steroid Avoidance Immunosuppression African Americans

Clinical trial NCT00189202 · COMPLETED

Trial details

NCT number
NCT00189202
Sponsor
University of Michigan
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
End Stage Renal DiseaseKidney Transplantation
Start date
2004-08-01
Primary completion
2008-07-01
Enrollment
49

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.